TRAK - ReposiTrak, Inc. Stock Analysis | Stock Taper
Logo
ReposiTrak, Inc.

TRAK

ReposiTrak, Inc. NYSE
$10.33 -2.18% (-0.23)

Market Cap $187.73 M
52w High $22.17
52w Low $6.94
Dividend Yield 0.59%
Frequency Quarterly
P/E 27.92
Volume 78.59K
Outstanding Shares 18.17M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2026 $5.88M $2.73M $1.99M 33.75% $0.11 $2.35M
Q2-2026 $5.86M $3.19M $1.69M 28.79% $0.09 $2.04M
Q1-2026 $5.97M $3.22M $1.82M 30.47% $0.1 $2.52M
Q4-2025 $5.76M $3.27M $1.8M 31.18% $0.09 $1.67M
Q3-2025 $5.91M $3.19M $1.97M 33.24% $0.1 $2.47M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2026 $26.41B $57.38B $6.88B $50.49B
Q2-2026 $28.71M $56.31M $6.59M $49.72M
Q1-2026 $28.79M $55.61M $5.44M $50.17M
Q4-2025 $28.57M $55.33M $5.81M $49.52M
Q3-2025 $28.13M $54.83M $5.91M $48.92M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2026 $1.99M $2.08M $-3.03M $-1.35M $-2.3M $2.08M
Q2-2026 $1.69M $2.24M $21K $-2.33M $-67.33K $2.24M
Q1-2026 $1.82M $1.54M $-20.36K $-1.29M $226K $1.53M
Q4-2025 $1.8M $1.66M $-6.15K $-1.22M $434.48K $1.65M
Q3-2025 $1.97M $1.43M $-12.55K $-1.33M $92.92K $1.43M

Revenue by Products

Product Q3-2025Q4-2025Q2-2026Q3-2026
Professional Services
Professional Services
$0 $0 $0 $0
Subscription and Support
Subscription and Support
$10.00M $10.00M $10.00M $10.00M

Q3 2026 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at ReposiTrak, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

ReposiTrak combines steady revenue growth with outsized improvements in margins, cash generation, and balance‑sheet strength. It operates with very little debt, ample cash, and growing free cash flow, which gives it resilience and flexibility. In its chosen niche—food supply‑chain traceability and compliance—it benefits from powerful network effects, retailer‑mandated adoption, regulatory tailwinds, and industry endorsements. Together, these features create a business that looks both financially sound and competitively well positioned.

! Risks

Key risks include the company’s dependence on regulatory frameworks and the food and grocery sector, potential competition from larger technology and supply‑chain vendors, and the high share of goodwill and intangibles on the balance sheet, which could be impaired if performance falters. Negative, albeit improving, retained earnings still reflect historical losses. Finally, the absence of clearly reported R&D spending raises concerns about the transparency and scale of its innovation efforts in a market where technology leadership is critical.

Outlook

The overall direction of travel is positive: revenue is growing, margins are expanding, cash flows are strengthening, and the balance sheet has been de‑risked. If ReposiTrak can continue to expand its network, deepen partnerships, and build out advanced analytics while maintaining financial discipline, it is well positioned to benefit from the long‑term push toward greater food safety, transparency, and supply‑chain resilience. The sustainability of its competitive edge will depend on its ability to keep investing—explicitly or implicitly—in product development and to manage any emerging competition or regulatory shifts over time.